Technology have transformed urine analysis in pregnancy. The responsibility for urine testing in antenatal care remains with health care provider. Monitoring have been self-testing for both blood and urine in diseases like diabetes. The changing child birth and NICE guideline advocated involvement of pts in antenatal care, which can improved by transferring of knowledge and skills. This survey is to evaluate opinions about pt self-testing and monitoring of urine during pregnancy in a UK district Hospital community. Methods: Questionnaire designed to evaluate pt and non-pt opinions of urine self-testing during pregnancy. Opinion evaluated were 67.6% pts & 32.4% others for:
• 83.7% perceive to have knowledge of urine testing in antenatal care.
• Knowledge analysis showed; 92.4% for protein, 74.3% glucose.
55.2% blood, 67.6% UTI.
• Diseases awareness and association with urinalysis;-PET 95%, Diabetes 92.1%, UTI 87.1% & Hypertension 61.4%.
• 81.6% felt pt are capable of self-testing during ANC.
• 82.5% support pt self-testing of urine with appropriate support, 7.8% does not & 9.7% don't know. Objectives: The aim of the study was to investigate the obstetric outcome of the women carriers of mitochondrial oxidative phosphorylation (OXPHOS) disorders mutation and to identify the frequent pregnancy complications. Methods: A retrospective review of obstetric history of women referred to our tertiary centre for prenatal screening of a mitochondrial disorder was carried out. All medical records were retrieved. Patients were divided into three groups: 1) women carrying heteroplasmic mitochondrial DNA (mtDNA) mutations 2) healthy women with a family history of mtDNA-related OXPHOS disorder, but no maternal mutation, 3) healthy women carrying heterozygote nuclear DNA (nDNA) mutations. Obstetric history and pregnancy complications were evaluated separately in the three groups and compared to the control group. Results: Seventy-five women were included: they had 287 cumulative pregnancies. There was no difference in obstetrical outcome of women in group 2, compared to the control group. Objectives: To quantify actograph output in healthy third trimester pregnancies and investigate this in relation to computerised cardiotocograph (CTG). Methods: 42 women between 24 to 34 weeks of gestation underwent an ultrasound growth scan followed by a computerised CTG. Post capture analysis of the actograph recording was performed and expressed as a percentage of activity over time.
The actograph output results were analysed in relation to short term variation (STV) and fetal accelerations. Results: There was no significant association of actograph output recording with STV (R =0.211; p = 0.178). However, accelerations >10bpm correlate significantly with actograph activity (R=0.387, p=0.015). Conclusions: Fetal movements assessed by the actograph are not associated with STV. As reduced STV is predictive of fetal acidosis, the lack of association was anticipated in healthy fetuses. However, we note that our data is limited by the fact that all traces were of a relatively short duration. We report that accelerations >10bpm were associated with actograph in our study. This suggests that actograph may be a reliable marker of movement quantification.
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